Company / EPS (Diluted)
PROCEPT BioRobotics Corp EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.24
FY2025
5-year range
-$14.47 / -$1.96
FY2021-FY2025
Trend
-14.3%
vs FY2024
Sector context
#136 of 159
Health Care
What the data says
PROCEPT BioRobotics Corp's eps (diluted) of $-2.24 is lower than 86% of companies in the Health Care sector (FY2025). Improved from $-3.63 to $-2.24 over the past 2 years.
Based on SEC 10-K filings.
-2.24 in FY2025.
Improved from $-3.63 to $-2.24 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 159This company -$2.24 Sector average $1.67
▼
-234.3% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 14.3% year-over-year.
- Ranks #136 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.24 | -14.3% |
| FY2024 | -$1.96 | +46.0% |
| FY2023 | -$3.63 | +0.0% |
| FY2022 | -$3.63 | +74.9% |
| FY2021 | -$14.47 | +0.0% |
| FY2020 | -$14.47 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026